To apply for the
fellowship program, you must supply the following:
Dana-Farber/Boston Children's Cancer and Blood
Disorders Center uses the Electronic Residency Application System (ERAS). For
more information on the ERAS system please visit the Association of American Medical Colleges website.
Please note, when in this application, visit the section called
Participating Specialties and Programs, then search for the Pediatric
Hematology/Oncology Fellowship Program. You will be directed to search for the
program name. Our program name is: Children’s Hospital/Boston Medical Center
Program. Please make sure that you click on that link. If not, you will be
redirected to a different application.
Medical school transcript
USMLE boards scores
(at least parts 1 and 2; part 3 if completed)
statement in the style requested on the application form
Three to five letters of reference from people with whom you
have worked closely in a clinical capacity or research capacity. All applicants
must supply at least three letters. MD/PhD applicants must also submit a
reference letter from their thesis advisor. If possible, all applicants should
supply at least one letter from a hematologist/oncologist or from someone who
has worked at Boston Children's Hospital or who is otherwise familiar with our
*Please make sure that all application materials are completed and turned in through the ERAS system. If your application is not received by the deadline mentioned below, your application will be marked incomplete and will not be accepted. The ERAS system will start to accept 2020 applications on July 5, 2019. We strongly recommend that you submit your application by July 15. However, we accept applications until December 3, assuming it is possible to schedule an interview between that date and the date of our selection committee meeting.
Sarah JohnsonFellowship Program CoordinatorBoston Children's HospitalEmail: firstname.lastname@example.orgPhone: 617-919-4242
U.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.
More than 70 years ago, Dr. Sidney Farber refused to accept that childhood cancer was untreatable. His determination led to the development of chemotherapy and the first remissions of childhood leukemia.